Abbott Laboratories 2013 Annual Report Download - page 33

Download and view the complete annual report

Please find page 33 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

31
ABBOTT 2013 ANNUAL REPORT
31
PROJECTED WORLDWIDE GROWTH
FOR IN VITRO DIAGNOSTICS
2012 2017
$28 billion
$35 billion
(estimated)
Leading Brands
ARCHITECT — Immunoassay systems and tests
ABBOTT PRISM — Blood-screening system
m2000 — Molecular testing system
CELL-DYN — Hematology analyzers
i-STAT — Point-of-Care testing system
2012
2017
$28 billion
$35 billion
(estimated)
Leading Brands
ARCHITECT — Immunoassay systems and tests
ABBOTT PRISM — Blood-screening system
m2000 — Molecular testing system
CELL-DYN — Hematology analyzers
i-STAT — Point-of-Care testing system